Biosante Pharmaceuticals, Inc.
(847) 478-0500
111 Barclay Blvd., Ste. 280
Lincolnshire, Illinois,
USA
60069
biosante is an emerging pharmaceutical company developing a robust product pipeline of hormone replacement products to treat hormone deficiencies in men and women. biosante also is developing its nanoparticulate-based platform technology (cap) for novel vaccines, vaccine adjuvants and drug delivery systems.
- Year Established:
- 1996
Products & Services
-
- Biosante
- Biosante Pharmaceuticals
- Biosante
- Biovant
- Libigel; Libigel
- Bio-t-gel
- Libigel E/t
- Bio-e-gel
- Bio-ep-gel
- Elestrin
- Hsdd
- Hypoactive Sexual Desire Disorder
- Bioair
- Bio-air
- Hormone Replacement
- Testosterone
- Testosterone Deficiency
- Hypogonadism
- Estrogen
- Estrogen Deficiency
- Hormone Deficiency Men
- Hormone Deficiency Women
- Female Sexual Dysfunction
- Cap
- Calcium Phosphate
- Adjuvant
-
- Vaccine Adjuvant
- Drug Delivery
- Nanoparticulate-based Platform Technology
- Nanoparticles
- Estradiol
- Estradiol Patch
- Progestogen
- Testosterone Gel
- Estrogen Gel
- Progestogen Gel
- Inhaled Insulin
- Insulin Delivery
- Corixa Corporation
- Paladin Labs
- Id Vaccine
- Strep A
- Antex Biologics
- Antares Pharma
- Solvay Pharmaceuticals
- Chlamydia
- H. Pylori
- H Pylori
- Medi-ject
- Milk Protein Isolation
- Transgenic Livestock
- Transgenic Protein Delivery
Web Result
- BioSante Pharmaceuticals...
- About Us Overview Management Board of Directors Contact Us Products Overview LibiGel Elestrin The Pill-Plus Testosterone Gel For Men Partners & Licenses Overview Opportunities Therapeutic Areas Female Sexual Dysfunction Menopause Contraception Male Hypogonadism Investors Corporate Governance SEC Filings Request Information Forward-Looking Statements Newsroom News Releases Media Kit News Releas...
- BioSante Pharmaceuticals - Newsroom - News Releases
Website Links:
Biosante Pharmaceuticals, Inc. | - Analyst Coverage | - Events | - Oncology | - Webcasts | 05/10/2013 BioSante Pharmaceuticals,... | 06/10/2013 Leading Independent... | 06/20/2013 BioSante Pharmaceuticals... | 06/21/2013 BioSante Pharmaceuticals... | BioBioSante Pharmaceuticals... | BioSante Announces Additional... | BioSante Announces CaP... | BioSante Announces FDA... | BIOSANTE ANNOUNCES FIRST... | BioSante Announces Launch... | BioSante Announces Positive... | BioSante Encouraged by... | BioSante Exchanges $4... | BioSante Exchanges $5... | BioSante Featured on...
Own this business?
Request to update the information